This research demonstrates improved immunotherapy responses in colorectal cancer by targeting metal-dependent cell death mechanisms, implying potential treatment strategies.
Immune checkpoint blockade (ICB) shows limited efficacy in colorectal cancer (CRC), particularly in microsatellite-stable tumors characterized by an immunologically "cold" microenvironment. Notably, the high metabolic demand for copper and iron in CRC, together with metal overload-associated PD-L1 upregulation, makes cuproptosis and ferroptosis attractive targets to enhance ICB responsiveness. Here, we present a laser-activated lipid nanoplatform, CuFeS₂-CA-DAC-Lipo (CCDL), that orchestrates cuproptosis, ferroptosis, and pyroptosis while remodeling the tumor immune microenvironment. CuFeS₂ functions as a near-infrared II photothermal transducer and a source of copper and iron ions, inducing concurrent cuproptosis and ferroptosis via ion overload. Decitabine restores gasdermin E expression to couple oxidative stress with caspase-3-mediated pyroptosis, while chlorogenic acid repolarizes tumor-associated macrophages toward a pro-inflammatory phenotype. This coordinated multimodal cell-death cascade establishes a self-amplifying immunogenic circuit that suppresses tumor growth, sensitizes CRC to ICB, and elicits systemic antitumor immunity.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: